Updated EBMT/ESID inborn errors working party guidelines for haematopoietic stem cell transplantation for inborn errors of immunity and metabolism
Open Access
- 22 May 2026
- journal article
- review article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 61 (7) , 791-804
Abstract
No abstract availableKeywords
Funding Information
- Wellcome (222096/Z/20/Z)
- NIHR UCLH Biomedical Research Centre
This publication has 136 references indexed in Scilit:
- Pre-Transplant Immune Dysregulation Predicts for Poor Outcome Following Allogeneic Haematopoietic Stem Cell Transplantation in Adolescents and Adults with Inborn Errors of Immunity (IEI)Journal of Clinical Immunology, 2025
- Feasibility and Experiences of HCT in Resource-Constrained Settings2024
- A Case of XIAP Deficiency Successfully Managed with Tadekinig Alfa (rhIL-18BP)Journal of Clinical Immunology, 2022
- The Immune Deficiency and Dysregulation Activity (IDDA2.1 ‘Kaleidoscope’) Score and Other Clinical Measures in Inborn Errors of ImmunityJournal of Clinical Immunology, 2021
- Reduced Intensity Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Pediatric Inherited Immune Deficiencies and Bone Marrow Failure SyndromesJournal of Clinical Immunology, 2020
- Proposed Therapeutic Range of Treosulfan in Reduced Toxicity Pediatric Allogeneic Hematopoietic Stem Cell Transplant Conditioning: Results From a Prospective TrialClinical Pharmacology & Therapeutics, 2019
- Dosing anticancer drugs in infants: Current approach and recommendations from the Children's Oncology Group's Chemotherapy Standardization Task ForcePediatric Blood & Cancer, 2017
- DOCK8 Deficiency: Clinical and Immunological Phenotype and Treatment Options - a Review of 136 PatientsJournal of Clinical Immunology, 2015
- Population pharmacokinetics analysis of cyclophosphamide with genetic effects in patients undergoing hematopoietic stem cell transplantationEuropean Journal of Clinical Pharmacology, 2013
- Management of mucopolysaccharidosis type IH (Hurler's syndrome) presenting in infancy with severe dilated cardiomyopathy: a single institution's experienceJournal of Inherited Metabolic Disease, 2012